BNP PARIBAS ISSUANCE (P122I0) Share Price

I’ll take’m :-D

FAFO..

Buy the rumor, sell the news. Poorly managed week. Flat since Monday and that's a shame. Should have been huge. However no one here will remember this week in a year, and that includes me.
"Deep F%%^ Value". Not my quote.
Good luck to all.

KBLB doesn’t intend to produce silk.

Directly, no. Indirectly yes. What company large and small doesn't outsource. It will all come together. Look what they've outsourced already.

What’s that going to cost?

https://en.vietnamplus.vn/lam-dong-sericult

As is defending the CEO of a revoked ticker and thinking he will somehow make it up to "investors".


..


..

A bunch of ENZC posts on this used hardare direction at the ENZC page on Twitter/X.com
The part about the toxicology tests on IPV-1 came from the horse's mouth: CCC, spoken to me personally.

Sorry, best I can do, but Zhabilov shut the labs when word got out about his ITV-1 pro

All of THAT was successfully rebutted in the trial...

But Trumpty does not know what a rebuttal is. Just the other day, he called it a "refuttle."

CARM Congratulations. You really did and i sort of did too.
Bought in the 2s in Feb/March. It was founded by Saar Gill at Penn and the MRNA deal is great. This might bring serious benefit to patients.
Also theres a strong thematic connection between $VOR and Saar Gills work, but thats

Now if you could only get trump to stay awake.

News out, let’s squeeze some 30s

Wrong again Sherlock. I have said this before. The fake biden is president of the bankrupt corporation known as the United States OF America. The cabal is in charge of the phony biden. The military allowed this destruction to occur in order to avoid civil unrest by leftists. And those who are blind

do you know where Melania is right now?



https://i.imgur.com/4b4Wexn.png

Based on the dropout rate of the trofinetide study and the 70+% diarrhea rate, recruiting for the new Rett study shouldn't be too long. Especially given the rollover rate into the OLE and then compassionate use studies for 2-73.

Let's hope that goes quickly.

It will be

Codelco's Paloma Project in Maricunga: offers 49%, an investment of US$ 2,300 million and will start with evaporation
https://www.redimin.cl/el-proyecto-paloma-de-codelco-en-maricunga-ofrece-el-49-cifra-inversion-en-us-2-300-millones-y-partira-con-evaporacion/
In the presentation of th

When FEW said " We'd explore all options" if the stock stays below $1.00. Obviously he meant a R/S.

From my experience R/S's only are effective when fundamentals support it. I've seen is a dozen times. this is how it goes:
a) The company makes a bullish announcement and the sto

The original case against George Jarkesy was brought in 2013,

Correct.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=85999798&txt2find=Jarkesy

When I read the decision today I was trying to recall the judge who handled a lot of the SEC cases. He

Are The Rana Group of India a big deal in India. Apparently they own Erisha EV...???

I think it's possible that there won't be any rate cuts this year MrSmith18? That's what I'm reading in the news.

In this case do you think the FORW merger could drag on to 2025?

"Under my Administration CO2 emissions went down, and at the same time we became more American energy dominate which helps Americans at the gas pump and with their electricity bills."

Did it actually say that? If so, who's the genius who doesn't know how to spell "dominant"?

Fortunately LP and DCVAX have been curing lung cancer patients for ten years now. Eye rolls.

Absolutely, this is a team effort.

Looking good afternoon hours

newman2021, you are correct that the DCVax-L dendritic cell cancer vaccine does already target survivin. In my opinion, there is absolutely no need or extra benefit for SurVaxM to be added to or combined with DCVax-L. It would be unnecessarily redundant, and it would provide very little, to no addit

Probably not. They probably thought he was just a hardworking "miner".......

Although Deb had no qualms dispensing insider info and soliciting private placements.